Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management-Reference-Cited by-同舟云学术

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

Published:2017-01-28 Issue:7 Volume:11 Page:769-784
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

Harbord Marcus¹,Eliakim Rami²,Bettenworth Dominik³,Karmiris Konstantinos⁴,Katsanos Konstantinos⁵,Kopylov Uri⁶,Kucharzik Torsten⁷,Molnár Tamás⁸,Raine Tim⁹,Sebastian Shaji¹⁰,de Sousa Helena Tavares¹¹,Dignass Axel¹²,Carbonnel Franck¹³,

Affiliation:

1. Imperial College London, and Chelsea and Westminster Hospital, London, UK

2. Department of Gastroenterology and Hepatology, Chaim Sheba Medical Center, Tel Hashomer, Israel

3. Department of Medicine B, University Hospital Münster, Münster, Germany

4. Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Crete, Greece

5. Department of Gastroenterology and Hepatology, University and Medical School of Ioannina, Ioannina, Greece

6. Department of Gastroenterology, Tel-Hashomer Sheba Medical Center, and Sackler School of Medicine, Tel Aviv University, Israel

7. Department of Internal Medicine and Gastroenterology, Hospital Lüneburg, Lüneburg, Germany

8. First Department of Medicine, University of Szeged, Szeged, Hungary

9. Department of Medicine, University of Cambridge, Cambridge, UK

10. IBD Unit, Hull & East Yorkshire NHS Trust, Hull, UK

11. Gastroenterology Department, Algarve Hospital Center; Biomedical Sciences & Medicine Department, University of Algarve, Faro, Portugal

12. Department of Medicine I, Agaplesion Markus Hospital, Frankfurt/Main, Germany

13. Department of Gastroenterology, CHU Bicêtre, Université Paris Sud, Paris, France

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/11/7/769/26359590/jjx009.pdf

Reference320 articles.

1. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology;Can J Gastroenterol,2005

2. Cortisone in ulcerative colitis; final report on a therapeutic trial;Br Med J,1955

3. Predicting outcome in severe ulcerative colitis;Gut,1996

4. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression;Clin Gastroenterol Hepatol,2007

5. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis;Cochrane Database Syst Rev,2010

Cited by 964 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Race and Postoperative Outcomes in Patients with Inflammatory Bowel Disease;Digestive Diseases and Sciences;2024-09-11

2. Global, regional, and national burden of inflammatory bowel disease, 1990–2021: Insights from the global burden of disease 2021;International Journal of Colorectal Disease;2024-09-07

3. Use of upadacitinib in a child with refractory ulcerative colitis;Meditsinskiy sovet = Medical Council;2024-09-02

4. MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations;Digestive and Liver Disease;2024-09

5. Aloe emodin promotes mucosal healing by modifying the differentiation fate of enteroendocrine cells via regulating cellular free fatty acid sensitivity;Acta Pharmaceutica Sinica B;2024-09